Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost–effectiveness analysis by Katalina Chan, Kare Hansen, Sergey Muratov, Shoghag Khoudigian, Mark Lamotte

Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China by Mafalda Ramos, Peng Men, Xu Wang, Anastasia Ustyugova, Mark Lamotte

Get full text

Title not available by Maria De Francesco, Mark Lamotte, Paolo Antonio Ascierto, Paolo Di Rienzo, Yumi Asukai

Get full text

A novel decision model to predict the impact of weight management interventions: The Core Obesity Model by Sandra Lopes, Henrik H. Meincke, Mark Lamotte, Anamaria‐Vera Olivieri, Michael E. J. Lean

Get full text

Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study by Richard J. Auchus, Carine Courtillot, Adrian Dobs, Diala El-Maouche, Henrik Falhammar, Henrik Falhammar, Andre Lacroix, Mallory Farrar, Conor O’Donoghue, Milena Anatchkova, Katelyn Cutts, Natalie Taylor, Chuck Yonan, Mark Lamotte, Philippe Touraine

Get full text